Antiretroviral therapy in HIV-infected children can stop neurological damage

DALLAS July 24, 2002 Treating HIV-infected children with antiretroviral therapy can stop and potentially even reverse neurological damage caused by HIV, doctors from UT Southwestern Medical Center at Dallas report in an international study.

Neurological symptoms are often one of the first signs HIV has progressed to AIDS in children.

In the July 2002 issue of the Journal of Pediatrics, Dr. Octavio Ramilo, senior author of the study and an associate professor of pediatrics at UT Southwestern, and colleagues write that children with HIV often fail to reach developmental milestones, show impaired brain growth and have trouble with fine motor skills even before other signs of developing AIDS are manifested. When treated with antiretroviral therapy that targeted the central nervous system, however, children showed neurological improvement.

"The good news is antiretroviral therapy does work," Ramilo said. "In some children, the amount of virus in their brains became undetectable."

In adult patients, HIV attacks the brain late in the course of illness, causing memory loss and dementia.

"Kids don't have a developed immune system like adults, so the virus is able to spread much, much faster," he said.

Twenty-three children aged seven months to 10 years were enrolled in the study at the Hospital del Nino in Panama City, Panama. All of the children had been infected with HIV at birth. At the beginning of the study, 83 percent of the children showed neurological abnormalities. After 48 weeks on antiretroviral therapy, only 35 percent of the children continued to show neurological abnormalities.

"This study proves that HIV infects the central nervous system of children, causing severe neurological problems," Ramilo said. "The study underscores the importance of using antiretroviral agents which are active in the central nervous system for treatment of children infected with HIV. You can see the difference in kids treated

Contact: Mindy Baxter
UT Southwestern Medical Center

Page: 1 2

Related biology news :

1. Targeted therapy knocks out pediatric brain cancer in mice
2. New anti-inflammatory strategy for cancer therapy identified by UCSD researchers
3. Columbia research to examine gene influence on severity of peridontal disease, therapy response
4. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
5. The search for a kinder, gentler chemotherapy
6. Embryonic stem cell therapy shows steady benefits in rebuilding infarcted heart
7. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences
8. Gene changes linked to increased eye pressure may have implications for glaucoma therapy
9. Jefferson Lab detector technology aids development of cystic fibrosis therapy
10. Stroking up cellular therapy
11. Smart gene therapy protects against damage from heart attack

Post Your Comments:

(Date:5/6/2020)... , ... May 06, 2020 ... ... Brevitest Technologies (Houston, Texas, http://www.brevitest.com ) will become the latest out-of-state ... region of Baltimore’s Inner Harbor. , Brevitest has developed a point-of-care analyzer ...
(Date:5/1/2020)... ... April 30, 2020 , ... ... diseases, announced today that it had been awarded a contract from the Biomedical ... Secretary for Preparedness and Response at the U.S. Department of Health and Human ...
(Date:4/30/2020)... ... April 28, 2020 , ... Ever ... latest effort in providing timely and critical information to life science organizations as ... and health safety concerns. , “Providing the most up-to-date actionable guidance and information ...
Breaking Biology News(10 mins):
(Date:4/18/2020)... ... April 17, 2020 , ... NeuroFlow has ... (SBIR) program to support the expansion of its digital health platform enabling behavioral ... a rigorous merit-based review process, adds to NeuroFlow’s recent government awards . ...
(Date:4/7/2020)... ... 2020 , ... Red Nucleus, a leading provider of strategic ... release of at-home virtual learning resources for all client partners. , “With the ... our employees as we continue to implement measures to safeguard the well-being of ...
(Date:4/1/2020)... ... March 30, 2020 , ... A ... Immune Diagnostics (RID), formed earlier this year to bring telehealth to various government ... tests for COVID-19. Company officials are currently?awaiting an Emergency Use Authorization (EUA) waiver ...
(Date:4/1/2020)... CITY, and LA JOLLA, Calif. (PRWEB) , ... March 31, 2020 ... ... tools, and La Jolla Institute for Immunology (LJI), announced today that they will use ... allowing CoVIC to move therapeutic candidates to the clinic as early as this summer. ...
Breaking Biology Technology:
Cached News: